The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

CEO Haruo Naito highlighted a 9% year-on-year revenue increase to 601.2 billion yen, with a focus on the pharmaceutical business driving growth. Key contributors included LEQEMBI with a 28.1 billion ...

For the second time, Massachusetts General Hospital has transplanted a genetically edited pig kidney into a human.

Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...

Sangamo (SGMO) reported positive updated data from a Phase 1/2 study of its gene therapy candidate ST-920 in the treatment of Fabry disease. Read more here.

A pensioner who lives in the Outer Hebrides is forced to make a gruelling 125 mile journey by taxi, plane and ferry to receive life-saving treatment. Mary Jefferson, 73, needs kidney dialysis to keep ...

Mysuru: Mysuru district health authorities submitted a proposal to the state govt seeking the sanction an additional 24 ...

L3Harris Technologies, Inc. engages in the provision of defense and commercial technologies across the air, land, sea, space, and cyber domains. It operates through the following segments ...

In the meta-analysis, the investigators calculated overall pooled hazard ratios (HRs) for heart failure risk, and subgroup analyses evaluated this risk in a North American regional subgroup and in ...